It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Unlimited access to calorie-dense, palatable food is a hallmark of Western societies and substantially contributes to the worldwide rise of metabolic disorders. In addition to promoting overconsumption, palatable diets dampen daily intake patterns, further augmenting metabolic disruption. We developed a paradigm to reveal differential timing in the regulation of food intake behavior in mice. While homeostatic intake peaks in the active phase, conditioned place preference and choice experiments show an increased sensitivity to overeating on palatable food during the rest phase. This hedonic appetite rhythm is driven by endogenous circadian clocks in dopaminergic neurons of the ventral tegmental area (VTA). Mice with disrupted clock function in the VTA lose their hedonic overconsumption rhythms without affecting homeostatic intake. These findings assign a functional role of VTA clocks in modulating palatable feeding behaviors and identify a potential therapeutic route to counteract hyperphagy in an obesogenic environment.
In addition to promoting overconsumption, palatable diets dampen daily intake patterns, which further augments metabolic dysfunction. Here, the authors find that in mice, circadian clocks in dopaminergic neurons in the ventral tegmental area drive hedonic appetite rhythms.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 University of Lübeck, CBBM, Institute of Neurobiology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)
2 Max Planck Institute for Metabolism Research, Department of Neuronal Control of Metabolism, Cologne, Germany (GRID:grid.418034.a) (ISNI:0000 0004 4911 0702)
3 University of Lübeck, CBBM, Department of Neurology, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672)
4 Institute of Endocrinology and Diabetes, University of Lübeck, CBBM, Lübeck, Germany (GRID:grid.4562.5) (ISNI:0000 0001 0057 2672); Deutsches Zentrum für Diabetesforschung e. V. (DZD), Neuherberg, Deutschland (GRID:grid.4562.5)